AHL Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $7.34M | Buy |
195,285
+50,232
| +35% | +$1.89M | 0.11% | 335 |
|
|
2017
Q3 | $5.29M | Sell |
145,053
-18,834
| -11% | -$686K | 0.09% | 384 |
|
|
2017
Q2 | $6.46M | Buy |
163,887
+16,176
| +11% | +$638K | 0.14% | 249 |
|
|
2017
Q1 | $4.63M | Buy |
147,711
+137,169
| +1,301% | +$4.3M | 0.1% | 365 |
|
|
2016
Q4 | $329K | Sell |
10,542
-22,911
| -68% | -$715K | 0.01% | 947 |
|
|
2016
Q3 | $1.34M | Sell |
33,453
-38,613
| -54% | -$1.55M | 0.05% | 508 |
|
|
2016
Q2 | $2.4M | Buy |
72,066
+49,899
| +225% | +$1.66M | 0.13% | 209 |
|
|
2016
Q1 | $652K | Sell |
22,167
-13,125
| -37% | -$386K | 0.04% | 503 |
|
|
2015
Q4 | $929K | Buy |
35,292
+25,236
| +251% | +$664K | 0.07% | 369 |
|
|
2015
Q3 | $238K | Sell |
10,056
-359,694
| -97% | -$8.51M | 0.04% | 627 |
|
|
2015
Q2 | $8.78M | Buy |
369,750
+62,598
| +20% | +$1.49M | 0.35% | 27 |
|
|
2015
Q1 | $7.29M | Buy |
307,152
+55,266
| +22% | +$1.31M | 0.29% | 38 |
|
|
2014
Q4 | $5.35M | Sell |
251,886
-72,588
| -22% | -$1.54M | 0.28% | 38 |
|
|
2014
Q3 | $5.52M | Buy |
+324,474
| New | +$5.52M | 0.43% | 21 |
|